Year |
Citation |
Score |
2024 |
Barras BJ, Ling T, Rivas F. Recent Advances in Chemistry and Antioxidant/Anticancer Biology of Monoterpene and Meroterpenoid Natural Product. Molecules (Basel, Switzerland). 29. PMID 38202861 DOI: 10.3390/molecules29010279 |
0.577 |
|
2022 |
Ling T, Boyd L, Rivas F. Triterpenoids as Reactive Oxygen Species Modulators of Cell Fate. Chemical Research in Toxicology. 35: 569-584. PMID 35312315 DOI: 10.1021/acs.chemrestox.1c00428 |
0.506 |
|
2021 |
González-Cardenete MA, Rivas F, Basset R, Stadler M, Hering S, Padrón JM, Zaragozá RJ, Dea-Ayuela MA. Biological Profiling of Semisynthetic C19-Functionalized Ferruginol and Sugiol Analogues. Antibiotics (Basel, Switzerland). 10. PMID 33673350 DOI: 10.3390/antibiotics10020184 |
0.301 |
|
2020 |
Ling T, Hadi V, Bollinger J, Rivas F. Identification of rapid access to polycyclic systems via a base-catalyzed cascade cyclization reaction and their biological evaluation. Bioorganic Chemistry. 99: 103846. PMID 32334195 DOI: 10.1016/J.Bioorg.2020.103846 |
0.611 |
|
2020 |
Balasubramaniam S, Vijayan S, Goldman LV, May XA, Dodson K, Adhikari S, Rivas F, Watkins DL, Stoddard SV. Design and synthesis of diazine-based panobinostat analogues for HDAC8 inhibition. Beilstein Journal of Organic Chemistry. 16: 628-637. PMID 32318119 DOI: 10.3762/Bjoc.16.59 |
0.349 |
|
2019 |
Ling T, Miller DJ, Lang W, Griffith E, Rodríguez-Cortés A, El Ayachi I, Palacios G, Min J, Miranda-Carboni GA, Lee RE, Rivas F. Mechanistic insight on the mode of action of colletoic acid. Journal of Medicinal Chemistry. PMID 31294974 DOI: 10.1021/Acs.Jmedchem.9B00187 |
0.546 |
|
2019 |
Ling T, Lang WH, Maier J, Quintana Centurion M, Rivas F. Cytostatic and Cytotoxic Natural Products against Cancer Cell Models. Molecules (Basel, Switzerland). 24. PMID 31130671 DOI: 10.3390/Molecules24102012 |
0.63 |
|
2019 |
Ling T, Lang WH, Craig J, Potts MB, Budhraja A, Opferman J, Bollinger J, Maier J, Marsico TD, Rivas F. Studies of Jatrogossone A as a Reactive Oxygen Species Inducer in Cancer Cellular Models. Journal of Natural Products. PMID 31084028 DOI: 10.1021/Acs.Jnatprod.8B01087 |
0.587 |
|
2019 |
Ling T, Lang WH, Martinez-Montemayor MM, Rivas F. Development of ergosterol peroxide probes for cellular localisation studies. Organic & Biomolecular Chemistry. PMID 31025693 DOI: 10.1039/C9Ob00145J |
0.599 |
|
2019 |
Hamulić D, Stadler M, Hering S, Padrón JM, Bassett R, Rivas F, Loza-Mejía MA, Dea-Ayuela MA, González-Cardenete MA. Synthesis and Biological Studies of (+)-Liquiditerpenoic Acid A (Abietopinoic Acid) and Representative Analogues: SAR Studies. Journal of Natural Products. PMID 30840453 DOI: 10.1021/Acs.Jnatprod.8B00884 |
0.394 |
|
2019 |
Martínez-Montemayor MM, Ling T, Suárez-Arroyo IJ, Ortiz-Soto G, Santiago-Negrón CL, Lacourt-Ventura MY, Valentín-Acevedo A, Lang WH, Rivas F. Identification of Biologically Active Compounds and Synthesis of Improved Derivatives That Confer Anti-cancer Activities . Frontiers in Pharmacology. 10: 115. PMID 30837881 DOI: 10.3389/Fphar.2019.00115 |
0.597 |
|
2019 |
Santiago CL, Rivas F, Ling T, Suarez-Arroyo IJ, Ortiz G, Lacourt MY, Valentin A, Lang WH, Martínez-Montemayor MM. Abstract 1869: Mechanistic evaluation of ergosterol peroxide onin vitrobreast cancer models Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1869 |
0.524 |
|
2018 |
Kearney SE, Zahoránszky-Kőhalmi G, Brimacombe KR, Henderson MJ, Lynch C, Zhao T, Wan KK, Itkin Z, Dillon C, Shen M, Cheff DM, Lee TD, Bougie D, Cheng K, Coussens NP, ... ... Rivas F, et al. Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space. Acs Central Science. 4: 1727-1741. PMID 30648156 DOI: 10.1021/Acscentsci.8B00747 |
0.407 |
|
2018 |
Ling T, Maier J, Das S, Budhraja A, Bassett R, Potts MB, Shelat A, Rankovic Z, Opferman JT, Rivas F. Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents. European Journal of Medicinal Chemistry. 164: 391-398. PMID 30611980 DOI: 10.1016/J.Ejmech.2018.12.059 |
0.611 |
|
2018 |
Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F. Novel vitexin-inspired scaffold against leukemia. European Journal of Medicinal Chemistry. 146: 501-510. PMID 29407975 DOI: 10.1016/J.Ejmech.2018.01.004 |
0.615 |
|
2018 |
Lang W, Ling T, Lee J, Ueno NT, Rivas F. Abstract LB-B28: Abietane natural products as novel therapeutics against solid tumors Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Lb-B28 |
0.383 |
|
2017 |
Fatima I, El-Ayachi I, Taotao L, Lillo MA, Krutilina R, Seagroves TN, Radaszkiewicz TW, Hutnan M, Bryja V, Krum SA, Rivas F, Miranda-Carboni GA. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer. Plos One. 12: e0189864. PMID 29281678 DOI: 10.1371/Journal.Pone.0189864 |
0.309 |
|
2016 |
Gautam LN, Ling T, Lang W, Rivas F. Anti-proliferative evaluation of monoterpene derivatives against leukemia. European Journal of Medicinal Chemistry. 113: 75-80. PMID 26922230 DOI: 10.1016/J.Ejmech.2016.02.034 |
0.575 |
|
2016 |
Ling T, Gautam LN, Griffith E, Das S, Lang W, Shadrick WR, Shelat A, Lee R, Rivas F. Synthesis and evaluation of colletoic acid core derivatives. European Journal of Medicinal Chemistry. 110: 126-132. PMID 26820555 DOI: 10.1016/J.Ejmech.2016.01.027 |
0.574 |
|
2016 |
Gautam LNS, Ling T, Rivas F. Abstract B38: A novel (+)-dehydroabietylamine derivative shows activity against triple-negative breast cancer cells Cancer Research. 76. DOI: 10.1158/1538-7445.Fbcr15-B38 |
0.358 |
|
2016 |
Rivas F, Ling T. Advances toward the Synthesis of Functionalized γ-Lactams Organic Preparations and Procedures International. 48: 254-295. DOI: 10.1080/00304948.2016.1165059 |
0.57 |
|
2016 |
Ling T, Rivas F. All-carbon quaternary centers in natural products and medicinal chemistry: recent advances Tetrahedron. 72: 6729-6777. DOI: 10.1016/J.Tet.2016.09.002 |
0.55 |
|
2015 |
Ling T, Tran M, González MA, Gautam LN, Connelly M, Wood RK, Fatima I, Miranda-Carboni G, Rivas F. (+)-Dehydroabietylamine derivatives target triple-negative breast cancer. European Journal of Medicinal Chemistry. 102: 9-13. PMID 26241873 DOI: 10.1016/J.Ejmech.2015.07.034 |
0.577 |
|
2014 |
González MA, Clark J, Connelly M, Rivas F. Antimalarial activity of abietane ferruginol analogues possessing a phthalimide group. Bioorganic & Medicinal Chemistry Letters. 24: 5234-7. PMID 25316317 DOI: 10.1016/J.Bmcl.2014.09.061 |
0.359 |
|
2013 |
Zhai B, Clark J, Ling T, Connelly M, Medina-Bolivar F, Rivas F. Antimalarial evaluation of the chemical constituents of hairy root culture of Bixa orellana L. Molecules (Basel, Switzerland). 19: 756-66. PMID 24406786 DOI: 10.3390/Molecules19010756 |
0.552 |
|
2013 |
Ling T, Griffith E, Mitachi K, Rivas F. Scalable and divergent total synthesis of (+)-colletoic acid, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor. Organic Letters. 15: 5790-3. PMID 24175735 DOI: 10.1021/Ol402842U |
0.614 |
|
2013 |
Hadi V, Hotard M, Ling T, Salinas YG, Palacios G, Connelly M, Rivas F. Evaluation of Jatropha isabelli natural products and their synthetic analogs as potential antimalarial therapeutic agents. European Journal of Medicinal Chemistry. 65: 376-80. PMID 23747806 DOI: 10.1016/J.Ejmech.2013.04.030 |
0.615 |
|
2012 |
Mitachi K, Salinas YG, Connelly M, Jensen N, Ling T, Rivas F. Synthesis and structure-activity relationship of disubstituted benzamides as a novel class of antimalarial agents. Bioorganic & Medicinal Chemistry Letters. 22: 4536-9. PMID 22727641 DOI: 10.1016/J.Bmcl.2012.05.124 |
0.607 |
|
2011 |
Nicolaou KC, Ellery SP, Rivas F, Saye K, Rogers E, Workinger TJ, Schallenberger M, Tawatao R, Montero A, Hessell A, Romesberg F, Carson D, Burton D. Synthesis and biological evaluation of 2',4'- and 3',4'-bridged nucleoside analogues. Bioorganic & Medicinal Chemistry. 19: 5648-69. PMID 21840722 DOI: 10.1016/J.Bmc.2011.07.022 |
0.575 |
|
2010 |
Nicolaou KC, Aversa RJ, Jin J, Rivas F. Synthesis of the ABCDEFG ring system of maitotoxin. Journal of the American Chemical Society. 132: 6855-61. PMID 20415445 DOI: 10.1021/Ja102260Q |
0.724 |
|
2008 |
Nicolaou KC, Frederick MO, Burtoloso AC, Denton RM, Rivas F, Cole KP, Aversa RJ, Gibe R, Umezawa T, Suzuki T. Chemical Synthesis of the GHIJKLMNO Ring System of Maitotoxin. Journal of the American Chemical Society. 130: 7466-76. PMID 18481856 DOI: 10.1021/Ja801139F |
0.721 |
|
2006 |
Rüegg T, Calderón AI, Queiroz EF, Solís PN, Marston A, Rivas F, Ortega-Barría E, Hostettmann K, Gupta MP. 3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium. Journal of Ethnopharmacology. 103: 461-7. PMID 16266794 DOI: 10.1016/J.Jep.2005.09.014 |
0.316 |
|
2005 |
Rivas F, Ghosh S, Theodorakis EA. Synthetic studies toward the zoanthamine alkaloids: Synthesis of the fully functionalized BC ring motif Tetrahedron Letters. 46: 5281-5284. DOI: 10.1016/J.Tetlet.2005.06.037 |
0.696 |
|
2004 |
Ghosh S, Rivas F, Fischer D, González MA, Theodorakis EA. Stereoselective synthesis of the ABC ring system of norzoanthamine. Organic Letters. 6: 941-4. PMID 15012070 DOI: 10.1021/Ol036492C |
0.73 |
|
2004 |
González MA, Ghosh S, Rivas F, Fischer D, Theodorakis EA. Synthesis of (+)- and (-)-isocarvone Tetrahedron Letters. 45: 5039-5041. DOI: 10.1016/J.Tetlet.2004.04.181 |
0.735 |
|
2002 |
Ling T, Rivas F, Theodorakis EA. Stereoselective synthesis of the fully functionalized core fragment of terpentecin Tetrahedron Letters. 43: 9019-9022. DOI: 10.1016/S0040-4039(02)02314-6 |
0.719 |
|
1995 |
García Y, García-Granados A, Martínez A, Parra A, Rivas F, Arias JM. Microbial Transformations of 6α- and 6β-Eudesmanolides by Rhizopus nigricans Cultures Journal of Natural Products. 58: 1498-1507. DOI: 10.1021/Np50124A004 |
0.322 |
|
1992 |
Bretón JL, Cejudo JJ, García-Granados A, Parra A, Rivas F. Partial synthesis of 6β-sesquiterpenolides from 6α-sesquiterpenolides Tetrahedron Letters. 33: 3935-3938. DOI: 10.1016/S0040-4039(00)74823-4 |
0.311 |
|
Show low-probability matches. |